EBA
Eagle Bay Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,655
| Closed | -$215K | – | 119 |
|
|
2025
Q1 | $215K | Sell |
2,655
-325
| -11% | -$26.4K | 0.18% | 102 |
|
|
2024
Q4 | $268K | Hold |
2,980
| – | – | 0.17% | 91 |
|
|
2024
Q3 | $294K | Hold |
2,980
| – | – | 0.11% | 132 |
|
|
2024
Q2 | $276K | Hold |
2,980
| – | – | 0.17% | 92 |
|
|
2024
Q1 | $283K | Buy |
2,980
+43
| +1% | +$4.08K | 0.18% | 97 |
|
|
2023
Q4 | $262K | Hold |
2,937
| – | – | 0.17% | 99 |
|
|
2023
Q3 | $214K | Sell |
2,937
-398
| -12% | -$29.1K | 0.1% | 139 |
|
|
2023
Q2 | $277K | Buy |
3,335
+721
| +28% | +$60K | 0.16% | 94 |
|
|
2023
Q1 | $199K | Sell |
2,614
-417
| -14% | -$31.8K | 0.11% | 127 |
|
|
2022
Q4 | $252K | Sell |
3,031
-510
| -14% | -$42.3K | 0.14% | 108 |
|
|
2022
Q3 | $281K | Sell |
3,541
-1,210
| -25% | -$96K | 0.17% | 88 |
|
|
2022
Q2 | $353K | Buy |
4,751
+1,039
| +28% | +$77.2K | 0.21% | 77 |
|
|
2022
Q1 | $334K | Buy |
3,712
+2,373
| +177% | +$214K | 0.27% | 72 |
|
|
2021
Q4 | $288K | Buy |
+1,339
| New | +$288K | 0.18% | 76 |
|